SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DaiS who wrote (20250)4/2/1999 5:17:00 PM
From: AlienTech  Read Replies (2) of 23519
 
>>Pfizer has a 20% EPS growth rate to help justify its 90-100 year multiple. So in 12 years Pfizer will be selling 8 times more drugs to joyful US citizens. I guess that your ever increasing wealth will happily cover the increase in health insurance that this demands.<<

I remember last year how I kept wondering how PSFT had P/E of 100 and was still climbing, But everyone at the time was still going on yea, no problem, they have the growth and they will not be affected by asia or anything else, great management, great products, they are stealing and gaining market share. The best stock to own for the next millenia. Well it did go to a P/E of 150.. And now it has a P/E of 250 going forward so on a level it is still growing by leaps and bounds. But look at the chart. Well BAANF was a whole another story about how you can sell to yourself. Hey maybe that is what will happen with PFE, all the shareholders will now start eating pills for breakfast instead of cherios. Looking at MSFT's market cap next year will crash your machine without a hardware and software upgrade. Already close to the 1/2 trillion mark, next year when it crosses the trillion, intel chips and microsoft's operating systems will choke on the number.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext